Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$43.46
-0.42-0.97%
At close: Sep 10, 5:00 PM EST
$43.08
-0.38-0.87%
After Hours: 4:58 PM EST
Rapport Therapeutics Inc (RAPP) Stock Price, Quote, News & History
RAPPNASDAQ
Rapport Therapeutics (RAPP) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Rapport Therapeutics (RAPP) stock?
You can purchase shares of Rapport Therapeutics (NASDAQ:RAPP) through any online brokerage.
Who are Rapport Therapeutics (RAPP) competitors?
Other companies in Rapport Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
What is the forecast, or price target, for Rapport Therapeutics (RAPP) stock?
Rapport Therapeutics has a consensus price target of $49.91.
What is the current price for Rapport Therapeutics (RAPP)?
The stock price for Rapport Therapeutics (NASDAQ: RAPP) is $43.08 last updated September 10, 2026 at 4:58 PM EDT.
Does Rapport Therapeutics (RAPP) pay a dividend?
There are no upcoming dividends for Rapport Therapeutics.
When is Rapport Therapeutics (NASDAQ:RAPP) reporting earnings?
Rapport Therapeutics does not have any upcoming earnings scheduled.
Is Rapport Therapeutics (RAPP) going to split?
There is no upcoming split for Rapport Therapeutics.
What sector and industry does Rapport Therapeutics (RAPP) operate in?
Rapport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
